Quarterly Monitoring Reports: Overview Pacific AIDS Network Fall - - PowerPoint PPT Presentation

STOP HIV/AIDS Quarterly Monitoring Reports: Overview

Pacific AIDS Network Fall Meeting, Oct 23rd, 2014 Guillaume Colley Senior Data Analyst, BC-CfE

Introduction

• Efficacy of HIV Treatment as Prevention (TasP)

depends on overcoming numerous barriers:

– Financial and structural to access testing, care and treatment – Patient and provider-level barriers – Institutional barriers

• Longitudinal monitoring of TasP program is essential

to optimize individual and public health outcomes

Lourenço et al., JAIDS 2014

Report creation process

• Collaborative approach
• Interdisciplinary team
• 13 indicators were chosen
• 1 report for the province + 1 report for each Health Authority
• Reports released quarterly, with a data lag of 6 weeks
• Available publicly on the BC CfE and the STOP HIV/AIDS

websites

Indicators: overview

• 1. Testing Episodes
• 2. HIV Testing Rate
• 3. New HIV Diagnoses
• 4. Stage of HIV Infection at Diagnosis
• 5. HIV Cascade of Care
• 6. Programmatic Compliance Score (PCS)
• 7. New Antiretroviral Starts
• 8. CD4 Cell Count at ART Initiation
• 9. Active and Inactive Drug Treatment Program Participants
• 10. Antiretroviral Adherence Level
• 11. Resistance Testing Results by Resistance Category
• 12. AIDS-Defining Illness
• 13. HIV-Related Mortality

Testing and Diagnosis Treatment and Care Resistance and Outcomes

Where appropriate, indicators are stratified by subgroups of interest, including HIV risk group and demographic characteristics.

Indicators: data sources

• British Columbia Center for Disease Control database (Testing,

Diagnosis, AIDS cases)

• Sunquest Laboratory database at the Provincial Public Health

Microbiology and Reference Laboratory (Testing, Diagnosis)

• Providence Health Care Laboratory (pVL, CD4, resistance)
• BC CfE Drug Treatment Program Database (ARV treatment)
• BC Vital Statistics database (Mortality)
• Limitations: see STOP HIV/AIDS Quarterly Monitoring

Technical Report

Indicator 1: Testing Episodes

• Provided by BCCDC
• POC tests are available only

after 2010 Q4

• Overall and stratified by

– Gender – Age – HA, HSDA

Indicator 2: Testing Rates

• Provided by BCCDC
• Overall and stratified by

– Gender – Age – HA, HSDA

Indicator 3: New HIV Diagnoses

• Provided by BCCDC
• Overall and stratified by

– Gender – Age – Exposure Category – HA, HSDA

Indicator 4: Stage of HIV Infection at Diagnosis

• Provided by BCCDC
• Overall and stratified by

– Gender – Age – Exposure Category

Indicator 5: HIV Cascade of Care

• Overall and stratified by

– Gender – Age – MSM status – IDU status – MSM by Age Category – HA, HSDA

• Estimates are used to complete Indicator

5 (Linkage and Retention stages of the Cascade) as the fully linked STOP cohort is not timely enough to allow current reporting

Indicator 6: Programmatic Compliance Score (PCS)

Reference: Lima VD, Le A, Nosyk B, Barrios R, Yip B, et al. (2012) Development and Validation

• f a Composite Programmatic Assessment Tool for HIV Therapy. PLoS

ONE 7(11): e47859.

Indicator 7,8,9: ARV Uptake

Indicator 7,8,9: ARV Uptake

Indicator 10: ARV Adherence

Indicator 11: Resistance Testing and Results

Indicator 12: AIDS Defining Illness

Indicator 13: HIV-Related Mortality

Documentation

• Reports: http://www.cfenet.ubc.ca/publications/centre-documents/stop-

hivaids-monitoring-reports

• Technical Report: http://stophivaids.ca/STOP/wp-content/uploads/ME-

Technical-Report-Complete_V4_25Nov2013.pdf

• Published article by Lourenço et al: Process Monitoring of an HIV Treatment

as Prevention Program in British Columbia, Canada.

THANK YOU